| 000 | 01892 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515013105.0 | ||
| 264 | 0 | _c20060406 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a0953-816X | ||
| 024 | 7 |
_a10.1111/j.1460-9568.2005.04550.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPhillips, Janice M | |
| 245 | 0 | 0 |
_aBlockade of mGluR glutamate receptors in the subthalamic nucleus ameliorates motor asymmetry in an animal model of Parkinson's disease. _h[electronic resource] |
| 260 |
_bThe European journal of neuroscience _cJan 2006 |
||
| 300 |
_a151-60 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 | _aFunctional Laterality |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aOxidopamine _xtoxicity |
| 650 | 0 | 4 |
_aParkinson Disease _xcomplications |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xdrug therapy |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReceptor, Metabotropic Glutamate 5 |
| 650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSubthalamic Nucleus _xdrug effects |
| 650 | 0 | 4 |
_aSympatholytics _xtoxicity |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLam, Hoa A | |
| 700 | 1 | _aAckerson, Larry C | |
| 700 | 1 | _aMaidment, Nigel T | |
| 773 | 0 |
_tThe European journal of neuroscience _gvol. 23 _gno. 1 _gp. 151-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1460-9568.2005.04550.x _zAvailable from publisher's website |
| 999 |
_c16036419 _d16036419 |
||